Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-25
2006-04-25
Lilling, Herbert J. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S007600, C514S019300, C514S021800, C514S183000, C514S185000, C530S385000
Reexamination Certificate
active
07033999
ABSTRACT:
Nitrosylation of proteins and amino acid groups enables selective regulation of protein function, and also endows the proteins and amino acids with additional smooth muscle relaxant and platelet inhibitory capabilities. Thus, the invention relates to novel compounds achieved by nitrosylation of protein thiols. Such compounds include: S-nitroso-heme proteins, S-nitroso-t-PA, S-nitroso-cathepsin; S-nitroso-lipoproteins; and S-nitroso-immunoglobulins. The invention also relates to therapeutic use if S-nitroso-protein compounds for regulating protein function, cellular metabolism and effecting vasodilation, platelet inhibition, relaxation of non-vascular smooth muscle, and increasing blood oxygen transport by hemoglobin and myoglobin. The compounds are also used to deliver nitric oxide in its most bioactive form in order to achieve the effects described above, or for in vitro nitrosylation of molecules present in the body. The invention also relates to the nitrosylation of oxygen, carbon and nitrogen moieties present on proteins and amino acids, and the use thereof to achieve the above physiological effects.
REFERENCES:
patent: 4703039 (1987-10-01), Hawiger et al.
patent: 4900719 (1990-02-01), Means et al.
patent: 5002964 (1991-03-01), Loscalzo
patent: 5025001 (1991-06-01), Loscalzo et al.
patent: 5116861 (1992-05-01), Goto et al.
patent: 5187183 (1993-02-01), Loscalzo et al.
patent: 5356890 (1994-10-01), Loscalzo et al.
patent: 5380758 (1995-01-01), Stamler
patent: 5525357 (1996-06-01), Keefer et al.
patent: 5545614 (1996-08-01), Stamler
patent: 5574068 (1996-11-01), Stamler
patent: 5583101 (1996-12-01), Stamler et al.
patent: 5593876 (1997-01-01), Stamler et al.
patent: 5840851 (1998-11-01), Plomer et al.
patent: 5863890 (1999-01-01), Stamler et al.
patent: 6197745 (2001-03-01), Stamler
patent: 6291424 (2001-09-01), Stamler et al.
European Search Report for European Application No. 00108906.9-2107—(Sep. 26, 2000).
McNamara et al, Canadian Journal of Physiology and Pharmacology, 58 (12):1446-1456 (1980) (Abstract).
Gruetter et al, Journal of Pharmacology and Experimental Therapeutics, 214(1):9-15 (1980) (Abstract).
Jansen et al, Journal of Pharmacology and Experimental Therapeutics, 261(1):154-160 (1992) (Abstract).
Stamler et al, Biology of Nitric Oxide, 1:20-23 (1992).
Buga et al, European Journal of Pharmacology, 161:61-72 (1989).
Chong et al, Drug Metabolism and Disposition, 18(1):61-67 (1990).
Edwards et al, Biochemical Pharmacology, 30 (18):2531-2538 (1981).
Forstermann et al, Molecular Pharmacology, 38:7-13 (1990).
Ignarro, Circulation Research, 65(1):1-21 (Jul. 1989).
Ignarro et al, The Journal of Pharmacology and Experimental Therapeutics, 218(3):739-749 (1981).
Jia et al, Nature, 380:221-226 (Mar. 1996).
Kosaka et al, Free Radical Biology & Medicine, 7:653-658 (1989).
Loscalzo et al, The Journal of Pharmacology and Experimental Therapeutics, 249(3):726-729 (1989).
Loscalzo et al, The New England Journal of Medicine, 319(14) :925-931 (Oct. 1988).
Loscalzo, J. Clin. Invest., 76:703-708 (Aug. 1985).
Mahley et al, JAMA, 265(1):78-83 (Jan. 1991).
Mellion et al, Molecular Pharmacology, 23:653-664 (1983).
Myers et al, Nature, 345:161-163 (May 1990).
Stamler et al, Proc. Natl. Acad. Sci. USA, 89:8087-8091 (Sep. 1992).
Stamler et al, Proc. Natl. Acad. Sci. USA, 89:7674-7677 (Aug. 1992).
Stamler et al, Proc. Natl. Acad. Sci. USA, 89:444-448 (Jan. 1992).
Stamler et al, Circulation Research, 65 (3):789-795 (Sep. 1989).
Umemoto et al, Biochemical and Biophysical Research Communications, 151 (3):1326-1331 (Mar. 1988).
Loscalzo Joseph
Stamler Jonathan
Brigham and Women's Hospital
Lilling Herbert J.
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Nitrosated and nitrosylated heme proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrosated and nitrosylated heme proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrosated and nitrosylated heme proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3580897